China Pharma Holdings Inc (CPHI) — Free Cash Flow Generation Index
China Pharma Holdings Inc (CPHI) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of $281.16K represents 1% of operating cash flow ($291.08K). Read debt load of China Pharma Holdings Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China Pharma Holdings Inc Free Cash Flow Generation Index (2007–2019)
Historical FCF Generation Index trend for China Pharma Holdings Inc across 13 annual periods. Explore China Pharma Holdings Inc (CPHI) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for China Pharma Holdings Inc (2007–2019)
Year-by-year Free Cash Flow Generation Index for China Pharma Holdings Inc. For the full company profile including market capitalisation, see CPHI stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.78x | $472.31K | $608.31K | $136.00K | ▼ -19.1% |
| 2018 | 0.96x | $1.21 Million | $1.26 Million | $51.15K | ▲ +14.5% |
| 2017 | 0.84x | $704.74K | $841.22K | $136.48K | ▼ -10.2% |
| 2016 | 0.93x | $2.70 Million | $2.90 Million | $193.40K | ▲ +203.3% |
| 2015 | 0.31x | $1.03 Million | $3.35 Million | $2.32 Million | ▲ +210.7% |
| 2014 | -0.28x | $-1.27 Million | $4.57 Million | $5.84 Million | ▲ +77.2% |
| 2013 | -1.22x | $-10.50 Million | $8.60 Million | $19.09 Million | ▼ -231.1% |
| 2012 | -0.37x | $-1.34 Million | $3.64 Million | $4.99 Million | ▼ -530.3% |
| 2011 | -0.06x | $-306.42K | $5.24 Million | $5.54 Million | ▲ +83.3% |
| 2010 | -0.35x | $-2.73 Million | $7.79 Million | $10.52 Million | ▲ +20.2% |
| 2009 | -0.44x | $-4.69 Million | $10.67 Million | $15.36 Million | ▼ -47.4% |
| 2008 | -0.30x | $-1.95 Million | $6.54 Million | $8.49 Million | ▼ -346.0% |
| 2007 | -0.07x | $-187.37K | $2.80 Million | $2.99 Million | — |